Chinese research shows statins associated with reduction in death Analysis prompts calls for further clinical trials of cholesterol-reducing drugs Statins – drugs that lower cholesterol – could reduce the risk of death from women diagnosed with breast cancer by as much as 38%, a new analysis has found, prompting fresh calls for clinical trials. The new analysis of seven previous observational studies was presented at the American Society of Clinical Oncology in Chicago, by Dr Binliang Liu, of the National Cancer Center in Beijing. It examined the protective factors linked to the cholesterol-lowering lipophilic statins, and comes after research in April found breast cancer patients who took them were less likely to see their cancer come back.

Read more at www.theguardian.com